{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:25:12Z","timestamp":1782368712991,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Facial Plastic Surgery Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.fsc.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:53:44Z","timestamp":1689335624000},"page":"511-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuromodulators for Skin"],"prefix":"10.1016","volume":"31","author":[{"given":"Anya","family":"Costeloe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.fsc.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/11530110-000000000-00000","article-title":"Botulinum toxin: examining duration of effect in facial aesthetic applications","volume":"11","author":"Flynn","year":"2010","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2023.06.002_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A\u00a0multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.fsc.2023.06.002_bib3","first-page":"985","article-title":"IncobotulinumtoxinA demonstrates safety and prolonged duration of effect in a dose-ranging study for glabellar lines","volume":"19","author":"Kerscher","year":"2020","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"NP500","DOI":"10.1093\/asj\/sjaa220","article-title":"A\u00a0double-blind, randomized clinical trial to determine effects of increasing doses and dose-response relationship of incobotulinumtoxinA in the treatment of glabellar rhytids","volume":"41","author":"Polacco","year":"2021","journal-title":"Aesthetic Surg J"},{"issue":"9","key":"10.1016\/j.fsc.2023.06.002_bib5","first-page":"980","article-title":"AbobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines: a randomized, dose-escalating, double-blind study","volume":"20","author":"Joseph","year":"2021","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.fsc.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/asj\/sjac157","article-title":"Safety, pharmacodynamic response, and treatment satisfaction with onabotulinumtoxinA 40 U, 60 U, and 80 U in subjects with moderate to severe dynamic glabellar lines","volume":"42","author":"Joseph","year":"2022","journal-title":"Aesthetic Surg J"},{"issue":"4","key":"10.1016\/j.fsc.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/DSS.0000000000002846","article-title":"A\u00a0multicenter study to evaluate subject satisfaction with two treatments of abobotulinumtoxinA a year in the glabellar lines","volume":"47","author":"Schlessinger","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.fsc.2023.06.002_bib8","unstructured":"American Society of Plastic Surgeons InternetNational Clearinghouse of Plastic Surgery Procedural Statistics (2020) Available at: https:\/\/www.plasticsurgery.org\/documents\/News\/Statistics\/2020\/plastic-surgery-statistics-full-report-2020.pdf. Accessed May 26, 2023."},{"issue":"Suppl 4","key":"10.1016\/j.fsc.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1524-4725.2010.01711.x","article-title":"Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines","volume":"36","author":"Brandt","year":"2010","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.fsc.2023.06.002_bib10","first-page":"38","article-title":"Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines","volume":"11","author":"Glogau","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.fsc.2023.06.002_bib11","doi-asserted-by":"crossref","unstructured":"Malmirchegini R, Too P, Oliyai C, Joshi A. Revance's novel peptide excipient, RTP004, and its role in stabilizing daxibotulinumtoxinA (DAXI) against aggregation. Poster presented at: TOXINS 2019; January 16\u201319, 2019; Copenhagen, Denmark","DOI":"10.1016\/j.toxicon.2018.11.174"},{"issue":"1","key":"10.1016\/j.fsc.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PRS.0000000000006327","article-title":"DaxibotulinumtoxinA for injection for the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)","volume":"145","author":"Carruthers","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.fsc.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaad.2019.06.1313","article-title":"DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)","volume":"82","author":"Bertucci","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.fsc.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/asj\/sjab329","article-title":"Long-term efficacy and safety of liquid abobotulinumtoxinA formulation for moderate-to-severe glabellar lines: a phase III, double-blind, randomized, placebo-controlled and open-label study","volume":"42","author":"Kestemont","year":"2022","journal-title":"Aesthetic Surg J"},{"issue":"6","key":"10.1016\/j.fsc.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"847e","DOI":"10.1097\/PRS.0000000000005029","article-title":"Safety and efficacy of EB-001, a novel type e botulinum toxin, in subjects with glabellar frown lines: results of a phase 2, randomized, placebo-controlled, ascending-dose study","volume":"142","author":"Yoelin","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.fsc.2023.06.002_bib16","series-title":"DYSPORT\u00ae (abobotulinumtoxinA) [package insert]","year":"2020"},{"key":"10.1016\/j.fsc.2023.06.002_bib17","series-title":"BOTOX\u00ae cosmetic (onabotulinumtoxinA) [package insert]","year":"2021"},{"key":"10.1016\/j.fsc.2023.06.002_bib18","series-title":"XEOMIN\u00ae (incobotulinumtoxinA) [package insert]","year":"2021"},{"key":"10.1016\/j.fsc.2023.06.002_bib19","series-title":"JEUVEAUTM (prabotulinumtoxinA-xvfs) [package insert]","year":"2019"},{"key":"10.1016\/j.fsc.2023.06.002_bib20","series-title":"DAXXIFYTM (daxibotulinumtoxinA-lanm) [package insert]","year":"2022"},{"key":"10.1016\/j.fsc.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.IOP.0000129012.09632.49","article-title":"Increased patient comfort utilizing botulinum toxin type A reconstituted with preserved versus nonpreserved saline","volume":"20","author":"Kwiat","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.fsc.2023.06.002_bib22","first-page":"2S","article-title":"Consensus recommendations on the use of botulinum toxin type A in facial aesthetics","volume":"11","author":"Carruthers","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.fsc.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1471-4914(03)00113-8","article-title":"Getting muscles moving again after botulinum toxin: novel therapeutic challenges","volume":"9","author":"Foran","year":"2003","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.fsc.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"864e","DOI":"10.1097\/PRS.0000000000003174","article-title":"An update on the anatomy of the forehead compartments","volume":"139","author":"Cotofana","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.fsc.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ca.23355","article-title":"Facial fold and crease development: a new morphological approach and classification","volume":"32","author":"Sandulescu","year":"2019","journal-title":"Clin Anat"},{"issue":"9","key":"10.1016\/j.fsc.2023.06.002_bib26","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","author":"Shah","year":"2008","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.fsc.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation","volume":"35","author":"Min","year":"2015","journal-title":"Aesthetic Surg J"},{"issue":"1","key":"10.1016\/j.fsc.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DSS.0000000000002494","article-title":"A\u00a0randomized, double-blinded study evaluating the safety and efficacy of abobotulinumtoxinA injections for oily skin of the forehead: a dose-response analysis","volume":"47","author":"Kesty","year":"2021","journal-title":"Dermatol Surg"},{"issue":"5 Suppl","key":"10.1016\/j.fsc.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1097\/PRS.0000000000001827","article-title":"Microbotox of the lower face and neck: evolution of a personal technique and its clinical effects","volume":"136","author":"Wu","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"3 Pt 1","key":"10.1016\/j.fsc.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin","volume":"39","author":"Rose","year":"2013","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.fsc.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"e1935","DOI":"10.1097\/GOX.0000000000001935","article-title":"Clinical effects on skin texture and hydration of the face using microbotox and microhyaluronicacid","volume":"6","author":"Kim","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"10.1016\/j.fsc.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1558944721994250","article-title":"Botulinum toxin A and B improve perfusion, increase flap survival, cause vasodilation, and prevent thrombosis: a systematic review and meta-analysis of controlled animal studies","volume":"18","author":"Goldberg","year":"2023","journal-title":"Hand (N Y)."},{"issue":"11","key":"10.1016\/j.fsc.2023.06.002_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1524-4725.2011.02109.x","article-title":"Botulinum toxin for the treatment of menopausal hot flushes: a pilot study","volume":"37","author":"Odo","year":"2011","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.fsc.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pain.2010.02.024","article-title":"Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin","volume":"149","author":"Carmichael","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.fsc.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/toxins13020120","article-title":"Therapeutic use of botulinum neurotoxins in dermatology: systematic review","volume":"13","author":"Martina","year":"2021","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.fsc.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/wrr.12204","article-title":"Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial","volume":"22","author":"Kim","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"9","key":"10.1016\/j.fsc.2023.06.002_bib37","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/jocd.13627","article-title":"Effect of botulinum toxin type A for treating hypertrophic scars: a split-scar, double-blind randomized controlled trial","volume":"19","author":"Elshahed","year":"2020","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.fsc.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0378-6323.173586","article-title":"Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars","volume":"82","author":"Elhefnawy","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.fsc.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast Surg"},{"issue":"5","key":"10.1016\/j.fsc.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dsu.12463","article-title":"Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies","volume":"40","author":"Cavallini","year":"2014","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.fsc.2023.06.002_bib41","first-page":"486","article-title":"Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration","volume":"14","author":"Sorensen","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.fsc.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ced.13108","article-title":"First case of anaphylaxis after botulinum toxin type A injection","volume":"42","author":"Moon","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"38","key":"10.1016\/j.fsc.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"e1610","DOI":"10.1097\/MD.0000000000001610","article-title":"Nonallergic eyelid edema after botulinum toxin type A injection: case report and review of literature","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"9","key":"10.1016\/j.fsc.2023.06.002_bib44","first-page":"929","article-title":"Mild to moderate dysphagia following very low-dose abobotulinumtoxin A for platysmal bands","volume":"16","author":"Obagi","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/toxins14020081","article-title":"High precision use of botulinum toxin type A (BONT-A) in aesthetics based on muscle atrophy, is muscular architecture reprogramming a possibility? A systematic review of literature on muscle atrophy after BoNT-A injections","volume":"14","author":"Nassif","year":"2022","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.fsc.2023.06.002_bib46","first-page":"121","article-title":"Effects of repeated botulinum toxin injections on orbicularis oculi muscle","volume":"12","author":"Borodic","year":"1992","journal-title":"J\u00a0Clin Neuro Ophthalmol"},{"issue":"5","key":"10.1016\/j.fsc.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1212\/WNL.48.5.1440","article-title":"Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia","volume":"48","author":"Ansved","year":"1997","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.fsc.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bjoms.2017.09.010","article-title":"Resorption of the mandibular condyle after injections of botulinum toxin A","volume":"55","author":"Aziz","year":"2017","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.fsc.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamafacial.2018.1962","article-title":"Treatment patterns and outcomes in botulinum therapy for patients with facial synkinesis","volume":"21","author":"Shinn","year":"2019","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1016\/j.fsc.2023.06.002_bib50","article-title":"Predicting depressor anguli oris excision outcomes using local muscle block","author":"O'Rourke","year":"2022","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"10.1016\/j.fsc.2023.06.002_bib51","article-title":"Chemodenervation of the posterior belly of the digastric muscle in facial synkinesis","author":"Longino","year":"2022","journal-title":"Facial Plast Surg Aesthet Med"},{"issue":"5 Suppl","key":"10.1016\/j.fsc.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1097\/PRS.0b013e31816de8d0","article-title":"Facial aesthetics consensus group faculty. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations","volume":"121","author":"Carruthers","year":"2008","journal-title":"Plast Reconstr Surg"}],"container-title":["Facial Plastic Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740623000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740623000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:22:50Z","timestamp":1761020570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064740623000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1064740623000676"],"URL":"https:\/\/doi.org\/10.1016\/j.fsc.2023.06.002","relation":{},"ISSN":["1064-7406"],"issn-type":[{"value":"1064-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromodulators for Skin","name":"articletitle","label":"Article Title"},{"value":"Facial Plastic Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsc.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}